Community-based directly-observed treatment for tuberculosis treatment

Project: Research

Project Details

Description

The National Tuberculosis and Leprosy Programme (NTLP) of Tanzania introduced the short treatment regimen for drug-sensitive TB, that includes rifampicin for the full 6 months, in 2006. Realizing that it would not to be able to sustain daily directly observed therapy (DOT) by a health professional, it embarked on a strategy to allow treatment supporters to observe treatment intake outside the direct health system.

The project describes the full cycle of assessing preference of patients, evaluation of the intervention, and monitoring implementation on the ground. CB-DOT is now an integral part of tuberculosis treatment delivery in Tanzania
AcronymCB-DOT
StatusFinished
Effective start/end date1/11/0531/12/12

Collaborative partners

  • Vrije Universiteit Amsterdam
  • National Tuberculosis and Leprosy Programme (lead)
  • National Institute for Medical Research (Project partner)
  • KNCV Tuberculosis Foundation (Project partner)
  • Novartis Foundation for Sustainable Development (Project partner)

UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This project contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.